A strain of a previously undescribed non-lipophilic coryneform bacterium was isolated from pleural fluids of a patient with chronic renal failure, stroke and pneumonia. Slow fermentative acid production from glucose, maltose and sucrose, and strong N-acetyl-p-glucosaminidase activity were the most characteristic features of the bacterium. Chemotaxonomic characterization unambiguously indicated that the organism belonged to the genus Corynebacterium. The results of comparative 165 rRNA gene sequence analysis revealed that the isolate represented a new species within the genus, for which the name Corynebacterium thomssenii sp. nov. is proposed. The type strain is DSM 44276.
INTRODUCTION
During the last few years there has been an increase in descriptions of new Corynebacterium species (7, 9, 19, 20) isolated from human clinical material. Currently, the genus Corynebacterium comprises more than 35 species, most of which are considered medically relevant (lo) , whereas in Bergey's Manual of Systematic Bacteriology only seven of the 17 Corynebacteriurn species listed are considered to be pathogenic (3, 10) . In recent years, the greater number of immunocompromised patients has increased interest in corynebacteria as serious opportunistic pathogens (4, 10) . We describe a novel Corynebacterium isolated in pure culture from a normally sterile body site of a severely ill patient. In a polyphasic study, initiated to clarify the taxonomic position of the unknown strain, it was shown that this bacterium represented a new Corynebacterium species, for which the name Corynebacterium thomssenii is proposed.
The GenBank accession number for the 165 rDNA sequence reported in this paper is AF010474.
METHODS
Bacterial strain. The strain was isolated in 1995 in the Laboratory of Clinical Microbiology at the SiidharzKrankenhaus of Nordhausen, Germany, and was sent for further characterization to the Department of Medical Microbiology, University of Gottingen, Germany. It was isolated in pure culture from the pleural fluid of a 56-yearold man with chronic renal failure, stroke and pneumonia, and it initially grew aerobically on Columbia agar supplemented with 5 % sheep blood. Cultivation and tests of physiological properties. The strain was grown in air and in a 5 % C0,-enriched atmosphere (Anaerocult C; Merck) on Columbia agar (Merck) supplemented with 5 YO sheep blood at 37 "C for 48 h. Anaerobic cultures were grown on Columbia agar supplemented with 5 % sheep blood and incubated in a polystyrene jar using Anaerocult A to create an anaerobic atmosphere. For biochemical characterization the API CORYNE system (2), the API ZYM (16), and the API 50CH system in combination with the 50 CHE medium were used (all from bioM6rieux). The enzymic reactions of the API CORYNE system were read after 24 h at 37 "C and acid production from carbohydrates was read after 48 h of incubation at 37 "C. The API ZYM was read after 4 h at 37 "C according to the manufacturer's instructions. Acid production from carbohydrates in the API 50CH system was read after 5 d incubation at 37 "C. DNase activity was tested on DNase agar (Merck) incubated for 48 h at 37 "C. Hydrolysis of tyrosine was observed on media described previously (17) 00654 0 1998 IUMS 0. Zimmermann and others and a positive reaction was recorded if clearing of the medium was noted within 10 d incubation at 37 "C in air.
An ti m icro bi a I susce pti bi I i ty testing . Antimicrobial susceptibility patterns were detected by the disk diffusion method. The strain was grown on Mueller-Hinton agar (Oxoid) supplemented with 5 YO sheep blood. Inhibition zones were interpreted according to DIN (5). Subsequently, MICs for eight substances were determined by the Merlin Micronaut system (Merlin Diagnostics) as outlined previously (6). Chemotaxonomic investigations. The strain was cultivated on TSB agar YO (w/v) Trypticase Soy Broth (Becton Dickinson BBL) supplemented with 5 % sheep blood plus 1.5 % (w/v) Bacto-Agar (Difco)] at 37 "C for 48 h. Cell material for fatty and mycolic acid analyses was harvested from TSB-blood agar. Material for cell-wall analysis and menaquinones was obtained from cultures grown in TSB for 4 d at 37 "C on a rotary shaker (90 r.p.m.). Cells were harvested by centrifugation, washed twice with distilled water and freeze-dried. Amino acid and sugar analysis of whole-cell hydrolysates followed described procedures (24) . Isoprenoid quinones were extracted and purified using the small-scale integrated procedure of Minnikin et al. (1 5) . Dried preparations of the extracts were dissolved in 200 p12-propanol and filtered. One-ten microlitres of the mixtures were used for separation by HPLC without further purification. Menaquinones were separated on Lichrosorb RP-18 (Merck) at 40 "C using acetonitrile/2-propanol(65: 35, v/v) as solvent (12, 13) . Polar lipids were extracted, examined by two-dimensional TLC and identified using published procedures (15). Fatty acid methyl esters were prepared from 40-80 mg wet cells (14) and 0.3 ml of the extract was passed through a silica gel column (Analytichem Bond Elut; Varian) to trap the mycolic acids. The eluent was then used for the GC analysis of the fatty acid methyl esters. Trimethylsilylated derivatives of the mycolic acids were prepared by mixing the other aliquot of the extract with 0.1 ml of a solution containing n-methyl-n-(trimethylsily1)-heptafluorobutyramide and trimethylchloro-silane (1 0 : 1, v/v; Macherey & Nagel). The mixtures of fatty acid methyl esters and trimethylsilylated derivatives of free mycolic acids were analysed by capillary GC, using a Hewlett Packard model 5898A gas chromatograph run by Microbial Identification Software (Microbial ID). For fatty acid methyl ester analysis, standard Microbial Identification System conditions were used. The trimethylsilylated derivatives of the mycolic acids were analysed by high-temperature GC with a model 5790A gas chromatograph (Hewlett Packard) equipped with a flame-ionization detector and a 12 m type HT5 column (SGE) using H, as carrier gas at a flow rate of 30 ml min-l. The oven temperature was increased from 210 to 400 "C at a rate of 10 "C min-l. The final temperature was maintained for 7 min. Peaks of the derivatives were identified by comparing their retention times with those of known standard mycolic acids.
Determination of the 16SrRNA gene structure and phylogenetic analyses. The strain was cultivated at 37 "C for 48 h on TSB agar supplemented with 5 YO sheep blood. Extraction of genomic DNA and amplification of the 16s rDNA were carried out as described previously (1 8). PCR products were purified using the Prep-A-Gene kit (Bio-Rad) and sequenced directly using the Taq Dye Deoxy terminator cycle sequencing kit (Applied Biosystems). Purified sequencing reaction products were electrophoresed on a 6 % (w/w) polyacrylamide gel for 12 h using a model 373A automated sequencer (Applied Biosystems). The determined sequence was aligned with the sequences of reference organisms obtained from the EMBL database using the program PILEUP. The alignments were corrected manually and 140 bases at the 5' end of the molecule were omitted from further analysis because of alignment ambiguities in the hypervariable region V1. Levels of sequence similarity for approximately 1230 nucleotides were determined. Distance matrices were produced by using the program DISTANCES of the Wisconsin Sequence Analysis Package (1 1) and corrected for substitution rates by using Kimura's two-parameter method. A phylogenetic tree was constructed by the neighbour-joining method (2 1) by using the program GROWTREE of the same package. (10) showed that the isolate could be distinguished easily from all other non-lipophilic, fermentative corynebacteria by biochemical methods (Table 1) . Testing with API ZYM revealed the presence of the following enzymes : alkaline phosphatase, esterase, esterase lipase, leucine arylamidase, cystine arylamidase, acid phosphatase and N-acetyl-/3-glucosaminidase. Lipase, valine arylamidase, chymotrypsin, a-galactosidase, P-glucuronidase, a-glucosidase, /3-glucosidase, a-mannosidase and a-fucosidase activities were not detected. The presence of N-acetyl-P-glucosaminidase was notable because to date no other species within the genus Corynebacterium has this activity (Table 1 ) (2). Antimicrobial susceptibility testing revealed that the strain was susceptible to penicillin G, ampicillin, cefazoline, gentamicin, erythromycin, clindamycin, tetracycline and ciprofloxacin, but was resistant to oxacillin. Resistance to oxacillin has also been described for other coryneform bacteria (8, 22) . MIC determinations demonstrated that the strain was susceptible to (MIC in pg ml-l) : chloramphenicol (4), rifampicin (0-0625), teicoplanin (0.25) and vancomycin, but was resistant to aztreonam (> 64), cefetamet (> 64), ceftibuten (> 64) and fosfomycin (> 256). The chemotaxonomic features of the isolate were consistent with its classification in the genus Corynebacterium (3) . The cell wall contained arabinose and galactose as cell-wall sugars ; meso-diaminopimelic acid was the diamino acid; short-chain mycolic acids (C32-C3,) were present ; the polar lipids comprised diphosphatidylglycerol, phosphatidylglycerol, phosphatidylinositol and phosphatidylinositol mannosides ; the predominant cellular fatty acids were palmitic acid (33 YO), oleic acid (56%) and stearic acid (lo%), which are qualitatively the same in other Corynebacterium spp. (1) ; MK-8(H2) and MK-9(H2) were the predominant menaquinones and small amounts of MK-10(H2) were also found.
RESULTS AND DISCUSSION
To determine the phylogenetic position of the unknown bacterium, the gene encoding the 16s rRNA was amplified by PCR. An almost complete 16s rDNA sequence (1471 nucleotides) was obtained.
Comparison of the nucleotide sequence with other members of the high-G + C-content actinomycetes revealed the highest homologies (> 91-5 YO) with members of the genus Corynebacterium (Table 2 ). An unrooted tree constructed from a matrix of sequence similarities demonstrated that the unknown coryneform bacterium clustered within the other members of the genus Corynebacterium. It formed a distinct subgroup with C. coyleae, C. afermentans, ' C. genitalium ', C. mycetoides, C. auris, ' C. pseudogenitalium' and C. renale (Fig. 1) . From sequence divergence values it is evident that the unknown strain is a new species within the genus Corynebacterium, with ' C. genitalium' as its closest neighbour, sharing only 95.8 YO 16s rDNA sequence homology (23) .
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